Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma
about
A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation.Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cellsHuman herpesvirus 8--a novel human pathogenNucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigenThe significance of oral health in HIV diseaseHuman herpesvirus 6The viral etiology of AIDS-associated malignanciesThe conundrum of causality in tumor virology: the cases of KSHV and MCVMolecular Approaches to the Identification of Unculturable Infectious AgentsStrategies for Human Tumor Virus Discoveries: From Microscopic Observation to Digital Transcriptome SubtractionGenomic characterization of Japanese macaque rhadinovirus, a novel herpesvirus isolated from a nonhuman primate with a spontaneous inflammatory demyelinating diseaseMolecular virology of Kaposi's sarcoma-associated herpesvirusRapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug.Kaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin?Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcoma.Kaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation.Complex alternative cytoplasmic protein isoforms of the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 generated through noncanonical translation initiation.Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus.Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma.Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).Comparative pathobiology of Kaposi sarcoma-associated herpesvirus and related primate rhadinoviruses.Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivateA viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells.Auricular involvement of a multifocal non-AIDS Kaposi's sarcoma: a case report.Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter.High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populationsMapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein.Convicting a human tumor virus: guilt by association?Downregulation of IRF4 induces lytic reactivation of KSHV in primary effusion lymphoma cellsKSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming geneDistinct biology of Kaposi's sarcoma-associated herpesvirus from primary lesions and body cavity lymphomas.Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates?Characterization of two divergent lineages of macaque rhadinoviruses related to Kaposi's sarcoma-associated herpesvirusThree-dimensional structure of the human herpesvirus 8 capsid.The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity.A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus.
P2860
Q24293762-A2622F9D-0062-4F26-9005-1243B27DCA64Q24527215-925C6104-8B93-4D0D-873B-B7FF4188CFA5Q24530670-240AB47F-5028-4478-8141-B2C46937A4B5Q24650427-033D102E-449B-4B4E-AF6B-E37FF5E395C3Q24672438-DB5B2011-CADC-4D9F-9A00-F3122DA47E02Q24679855-ECD69EE8-18B0-4E77-A0AA-0E7F80B99535Q24683663-72D1ED3C-0290-44FA-958F-E310BE8902E2Q24685892-8D94F2F6-D1AF-45FD-852D-2B48521C1E05Q26863112-06A94FF3-9126-486E-8275-D28BCA454FD7Q27487576-20CC4A05-5DC8-4957-9D50-99EF7C7B43DAQ28072707-ACFB0501-9080-413B-AF1E-3CD080064DE3Q28277888-14580603-17A0-4983-8E8E-B5466C10BC39Q28363323-9EDB27CA-F75D-4705-B688-FD93760C52CBQ28476740-AD46A267-6540-4537-A6DD-123D02CBF3A9Q29394711-A5086F59-7115-4E6C-931B-F634ABC3F21CQ30380999-CAC50BFC-5333-4A64-BC30-15F0427168A2Q30482603-C1559310-5CA8-451E-8866-1D932DB40E5BQ30535717-ADA34571-B893-4E8E-A8C1-57BD65CC4E52Q30840864-8C3F2439-4939-45CC-8896-3CEA2B83DD9BQ30982439-8006ED03-8003-49F0-9CA5-F1ED92C88F8BQ33428328-1ED241F7-4E16-4C41-ADED-2569EFD77B0EQ33507742-A8626E8F-0D62-4E10-8FC0-58F3F798EFEBQ33558299-2D68AA8A-BD63-4437-8C29-1A585AE8B579Q33559699-940AF6EF-A699-4886-8841-E5762E9C9288Q33560572-163569BB-368A-4829-B691-0A9FF059AE44Q33623056-6BA105FF-9E12-4C7E-812B-ED4B61783094Q33628508-F1397D3E-6016-41CD-B5D1-5459624C0E66Q33641552-35ACC2FE-112F-409B-A4CC-878DE37FBC12Q33647633-785D8010-CE0F-4E0A-96B5-9A98D8CF61DDQ33669136-09D3F65F-546F-4AEB-BFC9-F2076C570A2FQ33679432-168F16A4-FBAF-41EB-9B3A-C828F56F8EBBQ33757221-4A433463-23C4-46A7-9BDE-A20F0DA62897Q33761091-8537457A-88AE-4EC4-9446-924CF36A8459Q33784194-EC1ABF0B-858E-4A10-A8CE-E99F0DF43665Q33786189-03FFDA24-8DC9-4B2F-859E-30C3B83DDCB5Q33793963-A9EFDD56-9A47-439F-976C-C648885E153FQ33805275-7D6D4338-35F1-4515-AA1A-C52663DA9513Q33811735-DC477630-54DB-41F2-9D62-E626213FC5FDQ33813261-19E31839-CE3F-4019-A684-D986B86658CEQ33815534-3A8DE119-037E-4756-BD0E-AEBFDD4EB227
P2860
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma
@ast
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma
@de
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma
@en
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma
@nl
type
label
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma
@ast
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma
@de
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma
@en
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma
@nl
altLabel
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae
@en
prefLabel
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma
@ast
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma
@de
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma
@en
Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma
@nl
P2093
P2860
P3181
P1433
P1476
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae
@en
P2093
D J McGeoch
D M Knowles
E Cesarman
G Dominguez
P E Pellett
P2860
P304
P3181
P407
P577
1996-01-01T00:00:00Z